These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8511798)

  • 21. Effects of monocrotaline and monocrotaline pyrrole on 5-hydroxytryptamine and paraquat uptake by lung slices.
    Hilliker KS; Garcia CM; Roth RA
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):179-97. PubMed ID: 6410470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged cell-cycle arrest associated with altered cdc2 kinase in monocrotaline pyrrole-treated pulmonary artery endothelial cells.
    Thomas HC; Lamé MW; Morin D; Wilson DW; Segall HJ
    Am J Respir Cell Mol Biol; 1998 Jul; 19(1):129-42. PubMed ID: 9651189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monocrotaline induce pulmonary hypertension in animal models].
    Alexandru B; Bogdan MA
    Pneumologia; 2001; 50(2):85-9. PubMed ID: 11584679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocrotaline pyrrole targets proteins with and without cysteine residues in the cytosol and membranes of human pulmonary artery endothelial cells.
    Lamé MW; Jones AD; Wilson DW; Segall HJ
    Proteomics; 2005 Nov; 5(17):4398-413. PubMed ID: 16222722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms and pathology of monocrotaline pulmonary toxicity.
    Wilson DW; Segall HJ; Pan LC; Lamé MW; Estep JE; Morin D
    Crit Rev Toxicol; 1992; 22(5-6):307-25. PubMed ID: 1489509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity of mitomycin C toward cultured pulmonary artery endothelium.
    Hoorn CM; Wagner JG; Petry TW; Roth RA
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):87-94. PubMed ID: 7839373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    Ganey PE; Sprugel KH; Hadley KB; Roth RA
    J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.
    Pan LC; Wilson DW; Segall HJ
    Toxicology; 1993 Mar; 79(1):21-35. PubMed ID: 8475497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophy and prolonged DNA synthesis in smooth muscle cells characterize pulmonary arterial wall thickening after monocrotaline pyrrole administration to rats.
    Lappin PB; Roth RA
    Toxicol Pathol; 1997; 25(4):372-80. PubMed ID: 9280120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injury to the isolated, perfused lung by exposure in vitro to monocrotaline pyrrole.
    Hilliker KS; Roth RA
    Exp Lung Res; 1985; 8(4):201-12. PubMed ID: 4043006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early indications of monocrotaline pyrrole-induced lung injury in rats.
    Schultze AE; Wagner JG; White SM; Roth RA
    Toxicol Appl Pharmacol; 1991 Jun; 109(1):41-50. PubMed ID: 2038748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity.
    Bruner LH; Bull RW; Roth RA
    Toxicol Appl Pharmacol; 1987 Oct; 91(1):1-12. PubMed ID: 3672514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
    Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
    Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
    Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocrotaline pyrrole alters DNA, RNA and protein synthesis in pulmonary artery endothelial cells.
    Hoorn CM; Roth RA
    Am J Physiol; 1992 Jun; 262(6 Pt 1):L740-7. PubMed ID: 1377453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monocrotaline pyrrole-induced megalocytosis of lung and breast epithelial cells: Disruption of plasma membrane and Golgi dynamics and an enhanced unfolded protein response.
    Mukhopadhyay S; Shah M; Patel K; Sehgal PB
    Toxicol Appl Pharmacol; 2006 Mar; 211(3):209-20. PubMed ID: 16000202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement is not involved in monocrotaline pyrrole-induced pulmonary injury.
    Bruner LH; Johnson KJ; Till GO; Roth RA
    Am J Physiol; 1988 Feb; 254(2 Pt 2):H258-64. PubMed ID: 3344816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
    Schultze AE; Wagner JG; Roth RA
    Toxicol Appl Pharmacol; 1991 Jul; 109(3):421-31. PubMed ID: 1830177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Golgi, trafficking, and mitosis dysfunctions in pulmonary arterial endothelial cells exposed to monocrotaline pyrrole and NO scavenging.
    Lee J; Reich R; Xu F; Sehgal PB
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L715-28. PubMed ID: 19648287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia.
    Ganey PE; Sprugel KH; White SM; Wagner JG; Roth RA
    Am J Physiol; 1988 Nov; 255(5 Pt 2):H1165-72. PubMed ID: 3189578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.